Skip to main content
. Author manuscript; available in PMC: 2014 May 15.
Published in final edited form as: Cochrane Database Syst Rev. 2013 Oct 23;10:CD001055. doi: 10.1002/14651858.CD001055.pub4
Methods Randomised controlled trial of a counselling intervention to support women to stop smoking in pregnancy and prevent relapse postpartum
The study was conducted in offices of the ‘University Associates in Obstetrics and Gynecology’ in Vermont (USA), with recruitment from October 1988 to October 1992
Participants Inclusion criteria: Woman who reported smoking 1 or more cigarettes per day at onset of pregnancy
Exclusion criteria: Not further specified.
Recruitment: Women recruited through the state-supported (Maternal and Infant Care) prenatal clinic for underserved women or attending the Adolescent clinic for women 12 to 18 years. 524/544 (96%) women who were invited agreed to participate and were randomised. 399 current smokers (C = 202, I = 197); 125 spontaneous quitters (C = 63, I = 62) (separate paper).
Baseline characteristics: Smokers: Mean cigarettes per day before pregnancy C = 25.1, I = 26.1; mean cigarettes per day at first prenatal visit: C = 11.8, I = 13.4. Another smoker in the household (C = 82.6%, I = 78.5%)
Mean age: 23 years, < high school (C = 41%, I = 48%), 27% married; medicaid recipients (C = 73.1%, I = 71.9%); Adolescent clinic (C = 13.5%, I = 11.9%)
Spontaneous quitters: Mean cigarettes per day before pregnancy (C = 14.1, I = 13.5). Other smokers in household (C = 64%, I = 70%)
Mean age: C = 21.9, I = 20.9; < high school (C = 27%, I = 36%); 29% married; Medicaid recipients (C = 68.1%, I = 65.1%); adolescent clinic (C = 14.9%, I = 11.4%)
Progress+ coding: Low SES.
Interventions Control: Physician acknowledged women’s smoking, gave a rationale for quitting, strong recommendation to quit and provided smoking cessation booklet designed for pregnant women. All participants received: baseline questionnaire, measurement of exhaled CO, and brief standardised health risk message from a research nurse about the effects of smoking on the fetus and pregnancy.
Intervention: A structured smoking cessation protocol provided by physicians trained in its use (Secker-Walker 1992) at 1st, 2nd, 3rd and 5th visits: acknowledging the woman’s smoking, her exhaled CO level, any progress towards quitting, rationale for and unambiguous recommendation to quit, asking how she felt about quitting and acknowledging her response, asking how she could be helped and telling her about the counsellor, eliciting a commitment to change smoking behaviour before the next prenatal visit and referring her to the counsellor. The aim was to gain her agreement to set a quit date, a date when she would quit for 24 hours or a date when she would cut her consumption by half. Counsellor advised women on ways to accomplish the behaviour change.
2nd, 3rd, 5th and 7th visit included praise for those who had quit with referral to counsellor for help in staying quit. 36 week visits included a briefer protocol followed with referral for those who wanted to change, praise for success and referral to a nurse counsellor if smoking
Main intervention strategy: Counselling (multiple intervention) compared to less intensive intervention
Intensity: Frequency (C = 1, I = 5), Duration (C = 1, I = 3).
Intervention provided by existing staff, with referral to a counsellor: Effectiveness study
Outcomes Biochemically validated 7-day point prevalence abstinence at 36 weeks’ gestation (late pregnancy *) and 1 year postpartum*. Mean cigarettes per day at 36 weeks’ gestation* and 12 months postpartum. Mean birthweight*. Low birthweight*
Relapse prevention at 36 weeks’ gestation (late pregnancy*) and 12 months postpartum reported in associated reference (Secker-Walker 1998b)
Preterm births* are reported in attrition and are re-included in both numerator and denominator for this outcome
Notes Methods included a detailed process evaluation of participants’ views and recall of provider advice. Sample size justification
Separate paper reports relationship between exhaled CO and birthweight (Secker-Walker 1997b)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias) All outcomes Unclear risk High attrition. More than 25% lost to follow-up in pregnancy and more than 30% lost to longer-term follow-up
Smokers: 109/399 (27% attrition) 24 (6%) women with miscarriage (14), fetal demise (5) and infant deaths (5) were excluded from analysis and are not reported by group allocation. Report states 376 women remain included (instead of 375) (C = 191, I = 185)
68 women transferred care (C = 34, I = 34) , 17 delivered before 36 weeks (C = 8, I = 9) and were not included in 36-week analysis 12 women withdrew from study (C = 5, I = 7) and 3 lost to follow-up (C = 3), and were re-included as continuing smokers in this review, but are not included in mean cigarettes per day or perinatal outcomes. 114 (I) and 110 (UC) were contacted 1 year after birth, including 16 (I) and 18 (UC) lost to follow-up during pregnancy. Women with adverse outcomes were not included in the analysis
Spontaneous quitters: 33/125 (26%) attrition. Women with miscarriage (5), abortion (1), infant death (1), pregnancy loss (1), moving to another clinic or moving (22; C = 13, I = 9), delivering before 36 weeks (I = 2). All excluded from analysis leaving C = 48, I = 44
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking abstinence (detection bias) Low risk Self-reported cessation with biochemical validation by exhaled CO (<6 ppm) or urinary cotinine (<500 ng/mL)
Blinding of participants and personnel (performance bias)
All outcomes
High risk Intervention by clinic staff. Notes flagged.
Blinding of outcome assessment (detection bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Methods included a detailed process evaluation of participants’ views and recall of provider advice and suggests ‘to a large extent the intervention was implemented as planned’
Equal baseline characteristics in study arms Unclear risk No significant differences except for larger proportion of women in intervention group had not made a quit attempt in the past
Contamination of control group Unclear risk No women in cessation group received cessation counselling beyond the physician advice. Though the same physician provided advice so unclear if this was influenced by the intervention